The second revaccination is not enough. This was stated by the head of the study on the effectiveness of the fourth vaccination against coronavirus in Israel, Gili Regev Yohai. She called the five-fold increase in the number of antibodies found “a good but insufficient effect.”
“We are seeing an increase in the number of antibodies, but the increase is not so impressive,” said Professor Gili Regev Yohai in an interview with the Israeli news website ynet.co.il, citing preliminary data from the study.
Shortly after the fourth vaccination, the level of antibodies is the same as after the third, the professor said. She hoped for a better effect from the second revaccination.
According to the scientist, the goal cannot be to get the coronavirus vaccine every four months.
However, Gili Regev Yohai stressed the need for revaccination for people who are at risk: residents of a country with weakened immunity and people over 60 years old. However, she is not sure “should everyone be vaccinated. We need more information to make a decision. “
Germany says this:
Coronavirus disease, even in mild form, threatens damage to the heart, lungs and kidneys
Restrictive measures will tighten again
Term of termination of the rental agreement
Compulsory health insurance will rise in price
“I have the right” in Germany: The correct calculation of vacation for an employee
Changes for supermarket customers in 2022
.